1. 109TiPAcSé immunotherapy trials: Anti-PD-1 therapy for adult patients with selected rare cancer types. (17th December 2018) Authors: Marabelle, A; Chevret, S; Janot, F; Escudier, B; Pouessel, D; Tournigand, C; Hoang-Xuan, K; Mortier, L; Rousseau, B J-C; Schlumberger, M J; Ray-Coquard, I L; Blay, J-Y; Niccoli, P; Jaccard, A; Couch, D; Hoog-Labouret, N; Pauporte, I; Massard, C Journal: Annals of oncology Issue: Volume 29(2018)Supplement 10 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1345PData-mining of 110 172 electronic patient records with the ConSoRe tool: An analysis of second primary cancer in a comprehensive cancer center. (23rd October 2018) Authors: Heudel, P; Durand, T; Fervers, B; Gomez, F; Rivoire, M; Bachelot, T; Claude, L; Chassagne-Clement, C; Pilleul, F; Mognetti, T; Devaux, Y; Soubirou, J-L; Lasset, C; Perol, D; Chvetzoff, G; Pezet, C; Beaupere, S; Zrounba, P; Blay, J-Y Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 1347TiPProof-of-concept study evaluating a new tool for standardising radiological assessment of tumour response to treatment in routine clinical practice. (23rd October 2018) Authors: Mastier, C; de la Fouchardière, C; Fayette, J; Sarabi, M; Heudel, P; Coulon, A; Banaste, N; Mercier-Bischoff, E; Barma, M; Brahmi, M; Cassier, P; Couchon Thaunat, S; Eberst, L; Fournier-Garin, G; Metral, P; Pilleul, F; Blay, J-Y Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 1601ONatural history of sarcomas and impact of reference centers in the nationwide NETSARC study on 35, 784 patients (pts) from 2010 to 2017. (23rd October 2018) Authors: Blay, J-Y; Toulmonde, M; Penel, N; Mir, O; Chevreau, C M; Anract, P; Bompas, E; Rios, M; Firmin, N; Italiano, A; Piperno-Neumann, S; Kurtz, J-E; Duffaud, F; Rosset, P; Bertucci, F; Perrin, C; Chemin, C; Ducimetiere, F; Gouin, F; Le Cesne, A Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 1611PDA phase II, multicenter study of the EZH2 inhibitor tazemetostat in adults (INI1-negative tumors cohort) (NCT02601950). (23rd October 2018) Authors: Stacchiotti, S; Blay, J-Y; Jones, R L; Demetri, G D D; Mir, O; Italiano, A; Thomas, D; Chen, T W-W; Schöffski, P; Gil, T; Jahan, T; Cote, G; Ratan, R; Attia, S; Roche, M; Daigle, S; Sapir, I; Clawson, A; Gounder, M Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 1613PDmTOR inhibitors in uterine and extra-uterine malignant PEComas: A multicenter international case series retrospective analysis. (23rd October 2018) Authors: Sanfilippo, R; Jones, R L; Provenzano, S; Antoniou, G; Blay, J-Y; Fumagalli, E; Stacchiotti, S; Bertulli, R M; Mir, O; Hindi, N; Brahmi, M; Dufresne, A; Dei Tos, A P; Casali, P G Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 44PCorrelation between an automated functional assay that predicts targeted agent (TA) sensitivity and the tumor response of the sorafenib treatment evaluated within the MOST clinical trial. (16th September 2018) Authors: Tredan, O; Zelichov, O; Barbash, Z; Daitsh, Y; Birnbaum, L; Tarcic, G; You, B; Cassier, P; de la Fouchardiere, C; Ray-Coquard, I L; Brahmi, M; Wang, Q; Attignon, V; Baudet, C; Fournier Garin, G; Agrapart, V; Dargenio, A; Chabaud, S; Perol, D; Blay, J-Y Journal: Annals of oncology Issue: Volume 29:Number 6(2018)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. 79PCell lineage context and type of genomic alteration predict for the therapeutic relevance of tyrosine kinase inhibitors in human cancers. (7th November 2019) Authors: Vanacker, H; Cassier, P A; Pérol, M; Saintigny, P; Eberst, L; Carbonnaux, M; Brahmi, M; Verlingue, L; Ray-Coquard, I L; Pérol, D; Blay, J-Y Journal: Annals of oncology Issue: Volume 30(2019)Supplement 7 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. 82PArcagen: An EORTC-SPECTA project to perform a molecular characterization of rare cancers: Results of the retrospective feasibility cohort. (7th November 2019) Authors: Vinches, M; Stevovic, A; Ray-Coquard, I L; Treilleux, I; Meeus, P; Aust, S; Floquet, A; Croce, S; Chalabreysse, L; Girard, N; Blay, J-Y; Morfouace, M Journal: Annals of oncology Issue: Volume 30(2019)Supplement 7 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Efficacy of trabectedin in malignant solitary fibrous tumors: a retrospective analysis from the French Sarcoma Group. Issue 1 (December 2015) Authors: Khalifa, J.; Ouali, M.; Chaltiel, L.; Le Guellec, S.; Le Cesne, A.; Blay, J-Y; Cousin, P.; Chaigneau, L.; Bompas, E.; Piperno-Neumann, S.; Bui-Nguyen, B.; Rios, M.; Delord, J-P; Penel, N.; Chevreau, C. Journal: BMC cancer Issue: Volume 15:Issue 1(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗